Cliff Asness’s Solid Biosciences SLDB Stock Holding History

Cliff Asness’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	137,085 -14,456	-10%	-$110K	﹤0.01%	2836
2026 Q1	$1.09M	Buy	151,541 +19,584	+15%	+$126K	﹤0.01%	2715
2025 Q4	$744K	Buy	131,957 +900	+0.7%	+$4.88K	﹤0.01%	2711
2025 Q3	$809K	Buy	131,057 +973	+0.7%	+$5.69K	﹤0.01%	2555
2025 Q2	$634K	Buy	130,084 +16,985	+15%	+$60K	﹤0.01%	2478
2025 Q1	$418K	Buy	+113,099	New	+$484K	﹤0.01%	2528
2024 Q4	–	Sell	-37,936	Closed	-$264K	–	2942
2024 Q3	$264K	Buy	+37,936	New	+$308K	﹤0.01%	2451
2022 Q3	–	Sell	-13,988	Closed	-$129K	–	2307
2022 Q2	$129K	Sell	13,988 -10,541	-43%	-$110K	﹤0.01%	2054
2022 Q1	$442K	Buy	24,529 +20,750	+549%	+$366K	﹤0.01%	1863
2021 Q4	$99K	Sell	3,779 -4,161	-52%	-$127K	﹤0.01%	2151
2021 Q3	$285K	Sell	7,940 -6,768	-46%	-$287K	﹤0.01%	2047
2021 Q2	$807K	Buy	14,708 +3,985	+37%	+$263K	﹤0.01%	1677
2021 Q1	$889K	Buy	+10,723	New	+$1.19M	﹤0.01%	1604
2019 Q3	–	Sell	-2,953	Closed	-$255K	–	2155
2019 Q2	$255K	Buy	+2,953	New	+$322K	﹤0.01%	1921

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cliff Asness's SLDB Position: Q2 2026 in Review

Cliff Asness reduced its Solid Biosciences (SLDB) stake by 9.5% in Q2 2026, selling an estimated $110K and leaving 137,085 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

Cliff Asness first reported a position in SLDB in Q2 2019 and has held it in 14 quarters since. 155 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Cliff Asness held 137,085 shares of Solid Biosciences worth $1.37M as of Q2 2026.
Cliff Asness sold 14,456 Solid Biosciences shares in Q2 2026, an estimated $110K.
Solid Biosciences made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2836 holding.
Cliff Asness first reported a position in Solid Biosciences in Q2 2019 and has held it in 14 quarters since.
155 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.